Hedley D - Search Results

1

T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.

Wang XN, Taylor PR, Skinner R, Jackson GH, Proctor SJ, Hedley D, Dickinson AM. Wang XN, et al. Among authors: hedley d. Transplantation. 2000 Aug 15;70(3):488-93. doi: 10.1097/00007890-200008150-00016. Transplantation. 2000. PMID: 10949192

2

Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia.

Powles RL, Morgenstern GR, Kay HE, McElwain TJ, Clink HM, Dady PJ, Barrett A, Jameson B, Depledge MH, Watson JG, Sloane J, Leigh M, Lumley H, Hedley D, Lawler SD, Filshie J, Robinson B. Powles RL, et al. Among authors: hedley d. Lancet. 1983 Mar 19;1(8325):612-5. doi: 10.1016/s0140-6736(83)91793-2. Lancet. 1983. PMID: 6131300

3

The place of bone-marrow transplantation in acute myelogenous leukaemia.

Powles RL, Morgenstern G, Clink HM, Hedley D, Bandini G, Lumley H, Watson JG, Lawson D, Spence D, Barrett A, Jameson B, Lawler S, Kay HE, McElwain TJ. Powles RL, et al. Among authors: hedley d. Lancet. 1980 May 17;1(8177):1047-50. doi: 10.1016/s0140-6736(80)91497-x. Lancet. 1980. PMID: 6103390

4

Acceleration of bone-marrow recovery by pre-treatment with cyclophosphamide in patients receiving high-dose melphalan.

Hedley DW, McElwain TJ, Millar JL, Gordon MY. Hedley DW, et al. Lancet. 1978 Nov 4;2(8097):966-8. doi: 10.1016/s0140-6736(78)92529-1. Lancet. 1978. PMID: 81990

5

Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation.

Cornbleet MA, McElwain TJ, Kumar PJ, Filshie J, Selby P, Carter RL, Hedley DW, Clark ML, Millar JL. Cornbleet MA, et al. Among authors: hedley dw. Br J Cancer. 1983 Sep;48(3):329-34. doi: 10.1038/bjc.1983.196. Br J Cancer. 1983. PMID: 6351883 Free PMC article.

6

High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma.

McElwain TJ, Hedley DW, Gordon MY, Jarman M, Millar JL, Pritchard J. McElwain TJ, et al. Among authors: hedley dw. Exp Hematol. 1979;7 Suppl 5:360-71. Exp Hematol. 1979. PMID: 400698

7

Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.

McElwain TJ, Hedley DW, Burton G, Clink HM, Gordon MY, Jarman M, Juttner CA, Millar JL, Milsted RA, Prentice G, Smith IE, Spence D, Woods M. McElwain TJ, et al. Among authors: hedley dw. Br J Cancer. 1979 Jul;40(1):72-80. doi: 10.1038/bjc.1979.142. Br J Cancer. 1979. PMID: 383125 Free PMC article.

8

Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.

Hedley DW, McElwain TJ, Currie GA. Hedley DW, et al. Br J Cancer. 1978 Apr;37(4):491-6. doi: 10.1038/bjc.1978.76. Br J Cancer. 1978. PMID: 646922 Free PMC article.

9

Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors.

Smith IE, Hedley DW, Powles TJ, McElwain TJ. Smith IE, et al. Among authors: hedley dw. Cancer Treat Rep. 1978 Oct;62(10):1427-33. Cancer Treat Rep. 1978. PMID: 709548 No abstract available.

10

Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.

Hedley DW, McElwain TJ, Currie GA. Hedley DW, et al. Eur J Cancer (1965). 1977 Oct;13(10):1169-73. doi: 10.1016/0014-2964(77)90017-2. Eur J Cancer (1965). 1977. PMID: 923614 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

403 results

Search Page